Progress in Neutron Capture Therapy for Cancer

  • Barry J. Allen
  • Douglas E. Moore
  • Baiba V. Harrington

Table of contents

  1. Front Matter
    Pages i-xxxi
  2. Projects Reviews

    1. R. G. Fairchild, V. Benary, J. Kalef-Ezra, S. K. Saraf, R. M. Brugger, A. Shih et al.
      Pages 1-6
    2. R. L. Moss, F. Stecher-Rasmussen, R. Huiskamp, L. Dewit, B. Mijnheer
      Pages 7-12
    3. Ronald V. Dorn III, Merle L. Griebenow, Arlene L. Ackermann, Lowell G. Miller, Patrick R. Gavin, David L. Miller et al.
      Pages 13-20
    4. R. Zamenhof, H. Madoc-Jones, O. Harling, D. Wazer, S. Saris, J. Yanch et al.
      Pages 21-26
    5. R. M. Brugger, J. A. Shih, H. S. Wu, H. B. Liu, X. S. Luo
      Pages 27-29
    6. A. Andersson, J. Andersson, J-O. Burgman, J. Capala, J. Carlsson, H. Condé et al.
      Pages 41-52
  3. Reactor Neutron Sources

    1. R. L. Moss, F. Stecher-Rasmussen, K. Ravensberg, G. Constantine, P. Watkins
      Pages 63-66
    2. P. Watkins, G. Constantine, F. Stecher-Rasmussen, W. Freudenreich, R. L. Moss, R. Ricchena
      Pages 71-73
    3. J. Gajewski, E. B. Ramsay, L. E. Reinstein, S. Saraf, R. Fairchild
      Pages 75-78
    4. G. J. Storr, B. J. Allen, B. V. Harrington, L. R. Davis, M. M. Elcombe, H. Meriaty
      Pages 79-82
    5. Otohiko Aizawa, Hiroshi Yamada
      Pages 87-90
    6. Orn-Anong Pettersson, Per Svensson, Börje Larsson, Erik Grusell
      Pages 91-93

About this book


Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988.


diagnosis imaging positron emission tomography surgery tissue

Editors and affiliations

  • Barry J. Allen
    • 1
  • Douglas E. Moore
    • 2
  • Baiba V. Harrington
    • 1
  1. 1.Australian Nuclear Science and Technology OrganisationMenaiAustralia
  2. 2.University of SydneySydneyAustralia

Bibliographic information

  • DOI
  • Copyright Information Plenum Press, New York 1992
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-6494-8
  • Online ISBN 978-1-4615-3384-9
  • About this book